Actinium Pharmaceuticals Inc banner

Wall St Price Targets

7AY1 Price Forecast
Based on 5 analysts

+379% Upside
from €0.891 today

Actinium Pharmaceuticals Inc (7AY1)’s 12-month stock price forecast through October 2027 has a consensus target of €4.272, implying 379% upside. The forecast is based on price targets from 5 Wall Street analysts.

7AY1 Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for 7AY1 yet.

Actinium Pharmaceuticals Inc Competitors:
Price Targets

Financial forecasts

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Value YoY Lowest–highest Analysts
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 7AY1's stock price target?
Price Target
4.272 EUR

According to Wall Street analysts, the average 1-year price target for 7AY1 is 4.272 EUR with a low forecast of 3.172 EUR and a high forecast of 5.497 EUR.

What is the Revenue forecast for Actinium Pharmaceuticals Inc?
Projected CAGR
201%

The compound annual growth rate for Revenue over the next 8 years is 201%.

Back to Top